NCT02814747View on ClinicalTrials.gov

Evaluate and Understand Preferences and Representations in Families of Patients With Regard to High-throughput Sequencing Technology for Diagnostic Purposes

NACompletedINTERVENTIONAL
Enrollment

530

Participants

Timeline

Start Date

Not specified

Primary Completion Date

February 29, 2016

Conditions
Rare Diseases
Interventions
OTHER

quantitive study: 500 patients likely to be candidates for HTS

OTHER

qualitative study: 30 patients who have benefited from HTS

Trial Locations (1)

21079

CHU Dijon Bourgogne, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT02814747 - Evaluate and Understand Preferences and Representations in Families of Patients With Regard to High-throughput Sequencing Technology for Diagnostic Purposes | Biotech Hunter | Biotech Hunter